Xometry Inc XMTR Q1 2026 Earnings Strong EPS Beat Amidst Limited Revenue Disclosure MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns Chemomab Therapeutics Ltd CMMB Q1 2026 Earnings WiderThanExpected Loss Amid PreClinical Progress Chemours Q1 2026 Earnings Strong EPS Surprise Despite Ongoing Headwinds KEP Q4 2025 Earnings EPS Misses Estimates Amid Cost Pressures Stock Slips ELBM Q4 2025 Earnings Deep EPS Miss Amid Strategic Progress Stock Gains Slightly